BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15331755)

  • 1. Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.
    Du Pasquier RA; Schmitz JE; Jean-Jacques J; Zheng Y; Gordon J; Khalili K; Letvin NL; Koralnik IJ
    J Virol; 2004 Sep; 78(18):10206-10. PubMed ID: 15331755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Schmitz JE; Zheng Y; Martin K; Peyerl FW; Lifton M; Gorgone D; Autissier P; Letvin NL; Koralnik IJ
    J Virol; 2003 Nov; 77(22):11918-26. PubMed ID: 14581528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.
    Chen Y; Trofe J; Gordon J; Autissier P; Woodle ES; Koralnik IJ
    J Clin Virol; 2008 Jun; 42(2):198-202. PubMed ID: 18295538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
    Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
    J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.
    Koralnik IJ; Du Pasquier RA; Kuroda MJ; Schmitz JE; Dang X; Zheng Y; Lifton M; Letvin NL
    J Immunol; 2002 Jan; 168(1):499-504. PubMed ID: 11751998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
    Koralnik IJ; Du Pasquier RA; Letvin NL
    J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy.
    Koralnik IJ
    J Neurovirol; 2002 Dec; 8 Suppl 2():59-65. PubMed ID: 12491153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cell culture-grown JC virus (primary human fetal glial cells and the JCI cell line) and recombinant JCV VP1 as antigen for the detection of anti-JCV antibody by haemagglutination inhibition.
    Knowles WA; Sasnauskas K
    J Virol Methods; 2003 Apr; 109(1):47-54. PubMed ID: 12668267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals.
    Sharma MC; Zhou W; Martinez J; Krymskaya L; Srivastava T; Haq W; Diamond DJ; Lacey SF
    Virology; 2006 Jun; 350(1):128-36. PubMed ID: 16600320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient.
    Balduzzi A; Lucchini G; Hirsch HH; Basso S; Cioni M; Rovelli A; Zincone A; Grimaldi M; Corti P; Bonanomi S; Biondi A; Locatelli F; Biagi E; Comoli P
    Bone Marrow Transplant; 2011 Jul; 46(7):987-92. PubMed ID: 20921942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Clark KW; Smith PS; Joseph JT; Mazullo JM; De Girolami U; Letvin NL; Koralnik IJ
    J Neurovirol; 2001 Aug; 7(4):318-22. PubMed ID: 11517410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.
    Perkins MR; Ryschkewitsch C; Liebner JC; Monaco MC; Himelfarb D; Ireland S; Roque A; Edward HL; Jensen PN; Remington G; Abraham T; Abraham J; Greenberg B; Kaufman C; LaGanke C; Monson NL; Xu X; Frohman E; Major EO; Douek DC
    PLoS Pathog; 2012; 8(11):e1003014. PubMed ID: 23144619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.
    Mani J; Wang L; Hückelhoven AG; Schmitt A; Gedvilaite A; Jin N; Kleist C; Ho AD; Schmitt M
    Oncotarget; 2017 Jan; 8(2):2485-2500. PubMed ID: 27705933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.
    Krymskaya L; Sharma MC; Martinez J; Haq W; Huang EC; Limaye AP; Diamond DJ; Lacey SF
    J Virol; 2005 Sep; 79(17):11170-8. PubMed ID: 16103168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients.
    Du Pasquier RA; Stein MC; Lima MA; Dang X; Jean-Jacques J; Zheng Y; Letvin NL; Koralnik IJ
    J Neuroimmunol; 2006 Jul; 176(1-2):181-6. PubMed ID: 16750575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies.
    Du Pasquier RA; Autissier P; Zheng Y; Jean-Jacques J; Koralnik IJ
    AIDS; 2005 Dec; 19(18):2069-76. PubMed ID: 16284455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy.
    Wüthrich C; Koralnik IJ
    J Neuropathol Exp Neurol; 2012 Jan; 71(1):54-65. PubMed ID: 22157619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy.
    Marzocchetti A; Lima M; Tompkins T; Kavanagh DG; Gandhi RT; O'Neill DW; Bhardwaj N; Koralnik IJ
    Virology; 2009 Jan; 383(2):173-7. PubMed ID: 19062062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy.
    Andréoletti L; Dubois V; Lescieux A; Dewilde A; Bocket L; Fleury HJ; Wattré P
    AIDS; 1999 Aug; 13(12):1469-75. PubMed ID: 10465069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.